J. Henri Bayle
Bellicum Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
CAR-T cell therapy research, Immune Cell Function and Interaction, Immunotherapy and Immune Responses, Signaling Pathways in Disease, Pancreatic function and diabetes
Most-Cited Works
- → The p53-mdm-2 autoregulatory feedback loop.(1993)1,791 cited
- → A Field of Myocardial-Endocardial NFAT Signaling Underlies Heart Valve Morphogenesis(2004)324 cited
- → Endocardial Brg1 Represses ADAMTS1 to Maintain the Microenvironment for Myocardial Morphogenesis(2008)255 cited
- → Rapamycin Analogs with Differential Binding Specificity Permit Orthogonal Control of Protein Activity(2006)206 cited
- → Conditional Protein Alleles Using Knockin Mice and a Chemical Inducer of Dimerization(2003)131 cited
- → Induced chromosome deletions cause hypersociability and other features of Williams–Beuren syndrome in mice(2009)108 cited
- → Alternatively Spliced Forms in the Carboxy-Terminal Domain of the p53 Protein Regulate Its Ability to Promote Annealing of Complementary Single Strands of Nucleic Acids(1995)107 cited
- → Regulated Expansion and Survival of Chimeric Antigen Receptor-Modified T Cells Using Small Molecule-Dependent Inducible MyD88/CD40(2017)104 cited
- → The carboxyl-terminal domain of the p53 protein regulates sequence-specific DNA binding through its nonspecific nucleic acid-binding activity.(1995)100 cited
- → Two-Dimensional Regulation of CAR-T Cell Therapy with Orthogonal Switches(2018)83 cited